{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:12Z","timestamp":1790812812130,"version":"4.1.0"},"reference-count":11,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:p>Understanding how the relevant medical community accepts new therapies is vital to patients, physicians, and society. Increasingly, focus is placed on how medical innovations are evaluated. But recognizing when a treatment has become accepted practice\u2014essentially, acceptance by the scientific community\u2014remains a challenge and a barrierto investigating treatment development. This report aims to demonstrate the theory, method, and limitations of a model for measuring a new metric that the authors term \u201cprogressive scholarly acceptance.\u201d<\/jats:p>\n<jats:p>A model was developed to identify when the scientific community has accepted an innovation, by observing when researchers have moved beyond the initial study of efficacy.<\/jats:p>\n<jats:p>This model could enable further investigations into the methods and influences of treatment development.<\/jats:p>","DOI":"10.3171\/2015.1.jns142661","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T14:02:17Z","timestamp":1438956137000},"page":"207-211","source":"Crossref","is-referenced-by-count":21,"title":["Evaluating innovation. Part 1: The concept of progressive scholarly acceptance"],"prefix":"10.3171","volume":"124","author":[{"given":"Zane","family":"Schnurman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Kondziolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns142661","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1001\/jama.289.15.1969","article-title":"Disseminating innovations in health care","volume":"289","author":"Berwick","year":"2003"},{"key":"b2-jns142661","series-title":"J Am Coll Surg","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.jamcollsurg.2008.02.011","article-title":"Responsible development and application of surgical innovations: a position statement of the Society of University Surgeons","volume":"206","author":"Biffl","year":"2008"},{"key":"b3-jns142661","series-title":"Technol Forecast Soc","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.techfore.2006.04.004","article-title":"Forecasting emerging technologies: Use of bibliometrics and patent analysis","volume":"73","author":"Daim","year":"2006"},{"key":"b4-jns142661"},{"key":"b5-jns142661","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0140-6736(95)92781-6","article-title":"Inpatient general medicine is evidence based","volume":"346","author":"Ellis","year":"1995"},{"key":"b6-jns142661","series-title":"Int J Radiat Oncol Biol Phys","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0360-3016(01)01606-6","article-title":"Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study","volume":"51","author":"Flickinger","year":"2001"},{"key":"b7-jns142661","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"940","DOI":"10.3171\/jns.1996.84.6.0940","article-title":"Stereotactic radiosurgery for trigeminal neuralgia: a multiinstitutional study using the gamma unit","volume":"84","author":"Kondziolka","year":"1996"},{"key":"b8-jns142661","series-title":"Diffusion of Innovations","author":"Rogers","year":"2003"},{"key":"b9-jns142661","series-title":"Ann Surg","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1097\/01.sla.0000242706.91771.ce","article-title":"Innovation in surgery: a historical perspective","volume":"244","author":"Riskin","year":"2006"},{"key":"b10-jns142661","series-title":"J Neurosurg","doi-asserted-by":"publisher","DOI":"10.3171\/20151.JNS142664","article-title":"Evaluating innovation. Part 2: Development in neurosurgery","author":"Schnurman","year":"2015"},{"key":"b11-jns142661","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1001\/jama.289.15.1969","article-title":"Presumed benefit: lessons from the American experience with marrow transplantation for breast cancer","volume":"324","author":"Welch","year":"2002"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/1\/article-p207.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/1\/article-p207.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/124\/1\/article-p207.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T09:59:25Z","timestamp":1709978365000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/124\/1\/article-p207.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":11,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3171\/2015.1.jns142661","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}